Medicare AdvantageCoverageMedium impact
MA00.002r, Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies
Independence Blue Cross·Endocrinology, Family Medicine, Internal Medicine·Medical Policy
Effective date
Dec 10, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA00.002r for Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies has been reissued effective December 10, 2025. This is a policy update that may affect billing and coverage requirements for glucose monitoring devices and supplies for Medicare Advantage patients.
Action Required
By December 10, 2025: Billing team should review the complete updated policy MA00.002r for any changes to coverage criteria, prior authorization requirements, or billing guidelines for continuous glucose monitors and blood glucose monitoring supplies for Medicare Advantage patients. Update billing procedures and staff training as needed based on the full policy content.